Our data identified Targeting protein for Xklp2 (TPX2) and TTK Protein Kinase (TTK), among others, as potential therapeutic targets for CRC, highlighting an essential role for those two genes in the regulation of cell cycle processes and as essential genes for CRC proliferation and organotypic growth. This evidence concerns the gene TTK and colorectal carcinoma.